Pulsenmore Ltd. (PLSM)

Healthcare · NCM

USD3.51+2.33% today

Fundamentals

Market capUSD22.30M

Revenue growth (YoY)+578.3%

Profit margin-39.6%

Return on equity-17.6%

52-week rangeUSD3.00 to USD12.97

Valuation and ratings

Moat score41/100

Overall rating39/100, Reduce

Pulsenmore Ltd. trades at USD3.51. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.

Our moat model scores it 41 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

About Pulsenmore Ltd.

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.

Industry: Medical DevicesEmployees: 71HQ: Israel

PLSM passes 2 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Hypergrowth

Revenue compounding above 30% a year. Extraordinary, unsustainable by definition, and occasionally the beginning of something enormous.

Healthcare and pharma

Drug companies are engines that convert one expiring monopoly into the next. The patent cliff is the whole investment case.

The full research page for PLSM, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Open PLSM in the app Free guides and screens

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.